|Sales Growth||Profit Growth||Expense Growth||Stock Price CAGR|
Claris lifescience initially started as Oracle Laboratories Limited in July 1994. They changed their name to Claris lifescience in 1999, and got themselves re-registered in Gujarat. The rapidly growing company chased the 1 billion turnover mark in 2002. With injectables as their forte, Claris lifescience limited has built a network across the world. They have approvals of various international regulators like US FDA, MHRA (UK), TGA (Australia), MCC (South Africa), ANVISA (Brasil), INVIMA (Colombia), and GCC FCDA. With their speciality in pharmaceuticals, Claris lifescience also work towards making the environment better by contributing to various social causes. They have also stepped up into the field of FMCG, and now they plan on investing in new businesses as well. They are listed in the national stock exchange and Bombay stock exchange.
Claris lifescience limited deals in
They have recently become a financial management company that aims to provide a platform and investment to budding entrepreneurs. Apart from doing their mainstream work, Claris support and encourage various social causes. They direct on building possibilities in the sports and fitness sector, building ecosystems for business and entrepreneurship, and directing the limelight on art & culture.
2017- Claris lifescience was awarded the best Indian company to work for by ECONOMIC TIMES.
In 2017 Claris Lifescience was awarded one of the best companies in the Healthcare Industry for the 8th year in a row.
MedAssests rewarded Claris Lifescience with a gold award in 2015.
Claris has earned the ‘Silver Award’ in the 13th Annual Greentech Safety Awards* 2014 in the Pharmaceutical sector for exceptional performance in Safety Management.
Received Gold Award in India Manufacturing Excellence Awards from Frost & Sullivan
Claris has for the 4th time seized the IDMA Quality Excellence Award in 2009, in the section of formulations unit for annual turnover above Rs. 100 crores
Invest Yadnya is an eLearning platform engaged in educating & simplifying the contents based on personal finance for all individuals. We have combined technology with financial planning expertise to assist an individual in meeting their financial objectives. We provide valuable time, money, and knowledge to create India’s financial literacy with Claris lifescience limited fundamental analysis.
Invest Yadnya provides an unbiased & transparent Claris lifescience limited share analysis. We keep on updating our data & supply the latest information. Our main objective is to assist our clients in research on 950+ companies, including Claris lifescience limited stock analysis.
We also provide our clients with the Claris lifescience ltd annual report to understand its financial position before making any investment decisions. Claris lifescience limited balance sheet offers a summary of how the company incurs revenues & expenses.
You will get to know the ratio analysis, cash flows, income and expenses, and the company's historical growth rate. Claris lifescience limited results help the clients understand its financial position before making any investment decisions. The investors are also able to identify the core values and worth of the company. We also provide the quarterly results of the company so that you get a clear idea. Invest confidently and in a secured manner at Invest Yadnya. Create a free account and search for all the details about Claris lifescience limited before making your investment.
We help our clients do extensive research on 950+ companies through Stock-O-Meter, including Claris lifescience share review.
We also provide our clients with the Claris lifescience limited share price graph. It helps the clients understand the financial position of the company before making any investment decisions.
Our website has information about 83 other trading sector companies that give insight into its financials. Companies include Adani Enterprise ,Borosil Ltd., Apollo Tyres, Black Rose Industries, SVP Global Ventures, Kavit Industries & many more.